Week by week expectations Understanding typical progression helps set realistic expectations and identify whether your protocol needs adjustment
Patients who gained weight while prescribed any of the GLP-1 medications studied had no statistically significant change in their TSH levels
What to record for IGF-1 LR3 so the work is reproducible Reproducibility in this area fails at the material-provenance step far more often than at the analysis step
These same types of modifications (fatty acid chains, albumin binding) that work for pure GLP-1 agonists also extend tirzepatides duration
Sections were then blocked with dual endogenous enzyme-blocking reagent (DEEB, Agilent/Dako, S200389-2) (10 minutes) and Avidin/Biotin/Sniper (Vector, SP-2001) (3 minutes each) in turn, followed by mouse anti-glucagon (Abcam, ab10988) (1:1,000, 30 minutes) and goat anti-mouse AP conjugate (Biocare Medical, MALPH521H) (30 minutes), and detected using Ferangi Blue (Biocare Medical, FB813H) (2 minutes)